ArticleMolecular genetics and metabolism reports2021

A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1.

Margaret Reynolds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.